Moreover, while direct eosinophil-mediated cytotoxicity has been demonstrated in vitro, eosinophil-dependent inhibition of tumor initiation in vivo occurs by IL-33-mediated effects upon CD8+ T cells in the tumor microenvironment (63). The gene discussed is CD8A; the disease is neoplasm.